Company Profile
Pulse Biosciences Stock Price, News & Analysis
- Ticker:
- PLSE
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
32.79 USD (+8.47%)
Close
Last updated: July 27, 2026
1.68B USD
Market cap
Why the stock is moving
As of Jul 27, 2026, PLSE closed up 8.47% at $32.79. No new same-company headline was identified in the current news window.
Company overview
Business overview
Pulse Biosciences is a medical technology company focused on nano-pulse stimulation and nonthermal cellular treatments. Its platform is intended to create new ways to treat tissue while preserving surrounding structures.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Pulse sits in medical devices and energy-based technology.
Business Model Characteristics
The company depends on technology adoption, clinical validation, and the expansion of its platform into new procedures.
Position Within the Biotechnology Landscape
Pulse is a niche medtech name whose valuation depends on product development and procedural adoption.
Future catalysts
Pulse Biosciences’s catalysts are Nano-Pulse Stimulation adoption in dermatology and surgery. The market will watch whether the platform keeps moving from interesting technology to repeatable commercial use.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
DNLI · Source: Denali Therapeutics
- 02
- 03
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
ICUI · Source: ICU Medical
- 04
Encompass Health increases and declares dividend on common stock
EHC · Source: Encompass Health Corporation
- 05
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
CLPT · Source: ClearPoint Neuro
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Pulse Biosciences (PLSE)?
Pulse Biosciences (PLSE) most recently closed at 32.79 USD, a +8.47% move versus the previous session.
What is the market cap of Pulse Biosciences (PLSE)?
Pulse Biosciences currently has a market capitalization of 1.68B USD on BioPharmSignal.
What does Pulse Biosciences do?
Pulse Biosciences is a medical technology company focused on nano-pulse stimulation and nonthermal cellular treatments. Its platform is intended to create new ways to treat tissue while preserving surrounding structures.
On which exchange is PLSE stock listed?
Pulse Biosciences (PLSE) is associated with NASDAQ, United States, Biopharma.
What is Pulse?
Pulse Biosciences’s catalysts are Nano-Pulse Stimulation adoption in dermatology and surgery.
Which conditions is Pulse Biosciences targeting with Pulse?
Pulse Biosciences is associated with dermatology based on its company overview and current catalyst commentary.
How does Pulse Biosciences describe recent progress with Pulse?
Pulse Biosciences’s catalysts are Nano-Pulse Stimulation adoption in dermatology and surgery.
What is Biosciences?
Pulse Biosciences is a medical technology company focused on nano-pulse stimulation and nonthermal cellular treatments.